Skip to main content

Featured

Holy Week Tensions Rise as Israel Blocks Cardinal from Entering Sacred Jerusalem Site

  Cardinal Pierbattista Pizzaballa, the Latin patriarch of Jerusalem, holds a prayer service to mark Palm Sunday, following the cancellation of the traditional Palm Sunday procession from the Mount of Olives, amid restrictions on gathering in large groups, in Jerusalem, March 29, 2026. Israeli police prevented Cardinal Pierbattista Pizzaballa, the Latin Patriarch of Jerusalem, from entering the Church of the Holy Sepulchre on Palm Sunday, prompting widespread criticism from Christian leaders and governments worldwide. Authorities cited security concerns linked to the ongoing U.S.-Israeli war with Iran, noting that all holy sites in Jerusalem’s Old City had been temporarily closed due to the threat of missile strikes. The Latin Patriarchate condemned the move as an unprecedented disruption of centuries‑old tradition, marking the first time church leaders were unable to celebrate Palm Sunday Mass at the historic site. Israeli Prime Minister Benjamin Netanyahu later stated that the ...
Post a Comment
Read more

article

Labels

Alzheimer’s vaccines get a boost from new drug approval

 

After decades of disappointment and controversy, the field of Alzheimer’s disease research has finally seen a breakthrough with the approval of the first drug that targets the underlying pathology of the condition. 

Aducanumab, a monoclonal antibody that clears amyloid plaques from the brain, was granted accelerated approval by the US Food and Drug Administration in June 2021, despite mixed results from clinical trials and objections from some experts. 

The drug’s approval has rekindled interest in other therapeutic approaches that aim to prevent or slow down the progression of Alzheimer’s, such as vaccines that stimulate the immune system to attack amyloid or tau, another protein that accumulates in the brains of people with the disease. 

Several vaccine candidates are currently in various stages of development and testing, and some researchers are optimistic that they could offer a more effective and convenient way to treat Alzheimer’s than infusions of antibodies.


Labels:

Comments

Post a Comment